Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
WINDLAS | BSE
-8.35
-1.98%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
04/12/2023
414.05
425.00
426.80
411.20
Windlas Biotech Limited contract development and manufacturing organization (CDMO) manufactures and trades in pharmaceutical products in India. It offers CDMO services including product discovery product development licensing and commercial manufacturing of generic products. The company also provides manufactures various domestic trade generics and over-the-counter brands which include nutraceutical and health supplement products through the online and offline channels. In addition it manufactures pills capsules pouches sachets and liquid bottles; and generic products portfolio comprises fixed dosage combinations fixed dosage plus modified release combinations customized generics and chewable or dispersible. It exports its products primarily to Cambodia Ivory Coast the Philippines Thailand Vietnam Myanmar and Sri Lanka. The company was incorporated in 2001 and is based in Gurugram India.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
Microcap (<300M USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
31.2%1 month
39.5%3 months
39.1%6 months
43.0%19.12
0
2.13
0.02
0.01
9.41
1.30
0
646.81M
8.64B
103.55M
0.94
10.06
20.80
15.00
11.34
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
50.80
Range1M
100.75
Range3M
153.65
Rel. volume
0.52
Price X volume
2.46M